Company* (Country; Symbol) |
Company* (Country; Symbol) |
Product |
Terms/Details (Date) |
| | |||
Agencourt Bioscience Corp.* |
Various companies |
Agencourt signed deals for distribution of its SPRI nucleic acid-purification chemistry technology |
Agencourt signed deals with GenWorks Pty. Ltd. (Australia and New Zealand), Bluestar Ltd. (India), Pharmatech Inc. (Korea), Biolaboratories Pte. Ltd. (Singapore) and Genetic Research Instrumentation Ltd. (UK and France) (1/21) |
|
|||
Ambion Inc.* |
Applied Biosystems Group (NYSE:ABI) |
Ambion's siRNA products and Applied Biosystems' PCR reagents |
The companies will co-market the products for performing and monitoring the gene-knockdown effects of RNA interference in mammalian systems (1/19) |
|
|||
Bioxel Pharma Inc. (Canada; TSE:BIP) |
Cell Therapeutics Inc. (CTIC) |
Bioxel will sell cGMP paclitaxel to CTI |
The deal is worth at least C$1.2M (US$895,000) to Bioxel (2/19) |
|
|||
Corautus Genetics Inc.* |
Qiagen NV (the Netherlands; QGENF) and Strathmann Biotech AG* (Germany) |
VEGF-2 plasmid for anticipated Phase III trials and future commercial use |
Strathmann and Qiagen will manufacture the product; terms were not disclosed (1/8) |
|
|||
Epoch Biosciences Inc. (EBIO) |
Celera Diagnostics (joint venture of Celera Genomics Group and Applied Biosystems Group) |
Nonexclusive deal for incorporation of Epoch technology into Celera products for certain infectious diseases |
The license allows Celera to sell TaqMan probes that use Epoch's minor-groove binder and quencher in certain products; Epoch gets license fees and royalties on any end sales (2/10) |
|
|||
SpectruMedix LLC* |
Transgenomic Inc. (TBIO) |
Transgenomic will distribute SpectruMedix's Reveal Genetic Analysis systems in Europe |
Transgenomic's European marketing and sales organization will market and service the systems; terms were not disclosed (1/21) |
|
|||
Nanogen Inc. (NGEN) |
Transgenomic Inc. (TBIO) |
Transgenomic will distribute Nanogen's NanoChip Molecular Biology Workstation in certain Western European countries |
Transgenomic's European marketing and sales organization will market and service the instrument; terms were not disclosed (1/15) |
|
|||
|
| |||
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
NYSE = New York Stock Exchange; TSE = Toronto Stock Exchange. | |||
